Neuland Laboratories consolidated net profit declines 58.84% in the March 2025 quarter
15 - May - 2025 12:00 | 21 days ago
Net profit of Neuland Laboratories declined 58.84% to Rs 27.81 crore in the quarter ended March 2025 as against Rs 67.56 crore during the previous quarter ended March 2024. Sales declined 14.71% to Rs 328.36 crore in the quarter ended March 2025 as against Rs 385.01 crore during the previous quarter ended March 2024.
For the full year,net profit declined 13.32% to Rs 260.11 crore in the year ended March 2025 as against Rs 300.08 crore during the previous year ended March 2024. Sales declined 5.24% to Rs 1476.84 crore in the year ended March 2025 as against Rs 1558.58 crore during the previous year ended March 2024.
Board of Neuland Laboratories recommends Final Dividend
15 - May - 2025 12:00 | 21 days ago
Neuland Laboratories announced that the Board of Directors of the Company at its meeting held on 15 May 2025, has recommended a Final Dividend of Rs.12 per share (i.e.120%), subject to the approval of the shareholders.
Neuland Laboratories consolidated net profit declines 58.84% in the March 2025 quarter
15 - May - 2025 12:00 | 21 days ago
Net profit of Neuland Laboratories declined 58.84% to Rs 27.81 crore in the quarter ended March 2025 as against Rs 67.56 crore during the previous quarter ended March 2024. Sales declined 14.71% to Rs 328.36 crore in the quarter ended March 2025 as against Rs 385.01 crore during the previous quarter ended March 2024.
For the full year,net profit declined 13.32% to Rs 260.11 crore in the year ended March 2025 as against Rs 300.08 crore during the previous year ended March 2024. Sales declined 5.24% to Rs 1476.84 crore in the year ended March 2025 as against Rs 1558.58 crore during the previous year ended March 2024.
Board of Neuland Laboratories recommends Final Dividend
15 - May - 2025 12:00 | 21 days ago
Neuland Laboratories announced that the Board of Directors of the Company at its meeting held on 15 May 2025, has recommended a Final Dividend of Rs.12 per share (i.e.120%), subject to the approval of the shareholders.
Neuland Laboratories consolidated net profit declines 58.84% in the March 2025 quarter
15 - May - 2025 12:00 | 21 days ago
Net profit of Neuland Laboratories declined 58.84% to Rs 27.81 crore in the quarter ended March 2025 as against Rs 67.56 crore during the previous quarter ended March 2024. Sales declined 14.71% to Rs 328.36 crore in the quarter ended March 2025 as against Rs 385.01 crore during the previous quarter ended March 2024.
For the full year,net profit declined 13.32% to Rs 260.11 crore in the year ended March 2025 as against Rs 300.08 crore during the previous year ended March 2024. Sales declined 5.24% to Rs 1476.84 crore in the year ended March 2025 as against Rs 1558.58 crore during the previous year ended March 2024.
Board of Neuland Laboratories recommends Final Dividend
15 - May - 2025 12:00 | 21 days ago
Neuland Laboratories announced that the Board of Directors of the Company at its meeting held on 15 May 2025, has recommended a Final Dividend of Rs.12 per share (i.e.120%), subject to the approval of the shareholders.
Neuland Laboratories consolidated net profit declines 58.84% in the March 2025 quarter
15 - May - 2025 12:00 | 21 days ago
Net profit of Neuland Laboratories declined 58.84% to Rs 27.81 crore in the quarter ended March 2025 as against Rs 67.56 crore during the previous quarter ended March 2024. Sales declined 14.71% to Rs 328.36 crore in the quarter ended March 2025 as against Rs 385.01 crore during the previous quarter ended March 2024.
For the full year,net profit declined 13.32% to Rs 260.11 crore in the year ended March 2025 as against Rs 300.08 crore during the previous year ended March 2024. Sales declined 5.24% to Rs 1476.84 crore in the year ended March 2025 as against Rs 1558.58 crore during the previous year ended March 2024.
Board of Neuland Laboratories recommends Final Dividend
15 - May - 2025 12:00 | 21 days ago
Neuland Laboratories announced that the Board of Directors of the Company at its meeting held on 15 May 2025, has recommended a Final Dividend of Rs.12 per share (i.e.120%), subject to the approval of the shareholders.
Neuland Laboratories consolidated net profit declines 58.84% in the March 2025 quarter
15 - May - 2025 12:00 | 21 days ago
Net profit of Neuland Laboratories declined 58.84% to Rs 27.81 crore in the quarter ended March 2025 as against Rs 67.56 crore during the previous quarter ended March 2024. Sales declined 14.71% to Rs 328.36 crore in the quarter ended March 2025 as against Rs 385.01 crore during the previous quarter ended March 2024.
For the full year,net profit declined 13.32% to Rs 260.11 crore in the year ended March 2025 as against Rs 300.08 crore during the previous year ended March 2024. Sales declined 5.24% to Rs 1476.84 crore in the year ended March 2025 as against Rs 1558.58 crore during the previous year ended March 2024.
Board of Neuland Laboratories recommends Final Dividend
15 - May - 2025 12:00 | 21 days ago
Neuland Laboratories announced that the Board of Directors of the Company at its meeting held on 15 May 2025, has recommended a Final Dividend of Rs.12 per share (i.e.120%), subject to the approval of the shareholders.